Universidade Estadual da ParaĂba - Brazil
Author Profile
SCOPUS
ORCID
🎓 Early academic pursuits
Camila De Oliveira melo began her journey into the world of pharmaceuticals with a bachelor’s degree in pharmacy from universidade estadual da paraĂba (uepb) in 2015. her early academic interests focused on innovative drug delivery systems, specifically the pre-formulation study of polymeric nanoparticles to carry l-asparaginase, a promising approach for cancer treatment. her drive to explore advanced biotechnological solutions led her to pursue a master’s degree in pharmaceutical sciences (2018), where she worked on pla nanoparticles containing spiro-acridinic derivatives with anticancer activity. her strong foundation in biotechnology and pharmacy culminated in her doctoral degree from rede nordeste de biotecnologia (renorbio) at universidade federal do rio grande do norte (ufrn), where she focused on drug delivery systems aimed at cancer therapy using spiro-acridinic derivatives.
🔬 Professional endeavors
Camila’s professional experience is deeply rooted in biotechnology and pharmaceutical sciences. she has worked extensively in developing polymeric nanoparticles, contributing to innovative cancer treatments. her research during her doctorate involved the development and biological evaluation of spiro-acridinic-derived drug delivery systems, demonstrating her commitment to advancing cancer therapies. her expertise also extends to the creation of nanoemulsions containing essential oils, which offer potential in various pharmaceutical applications. camila has shown consistent dedication to improving the efficacy and solubility of hydrophobic drugs through inclusion complexes, broadening her contribution to pharmaceutical sciences.
🧬 Contributions and research focus
Camila's primary research focus lies in the development of cutting-edge drug delivery systems. her work has emphasized the creation of polymeric nanoparticles, specifically pla-based systems, aimed at improving the accumulation of therapeutic agents in tumor tissues via the enhanced permeability and retention (epr) effect. Nanotecnologia her research has contributed significantly to the advancement of cancer treatment, with a focus on increasing the bioavailability and effectiveness of hydrophobic drugs. additionally, camila’s exploration of nanoemulsions and inclusion complexes has opened doors for future applications in drug solubility and targeted delivery.
🏆 Accolades and recognition
in 2022, camila was recognized as one of the six brazilian researchers selected for the prestigious course "nanobiotecnologia aplicada ao combate da covid19," funded by the ministry of science, technology, and innovations (mctic). this recognition highlights her role as a leading figure in nanotechnology applications in brazil, Nanotecnologia particularly her expertise in employing nanoparticles for critical health challenges like cancer and covid-19. her work has been supported by notable funding bodies like the foundation for research support of the state of paraĂba (fapesq), showcasing the trust in her research contributions.
🌍 Impact and influence
Camila’s contributions to cancer research, particularly in the area of nanoparticle-based drug delivery systems, have had a significant impact on the field of pharmaceutical biotechnology. her research has the potential to revolutionize cancer treatment by offering more effective drug delivery methods, enhancing drug Nanotecnologia solubility, and reducing side effects. her work on nanoemulsions and inclusion complexes also presents a wide range of pharmaceutical applications, influencing future research in drug development. camila's selection for the nanobiotechnology course reflects her growing influence in both national and international scientific communities.
đź”® Legacy and future contributions
Camila de Oliveira melo’s legacy lies in her groundbreaking research on nanoparticle-based drug delivery systems for cancer therapy. her work is a testament to her commitment to innovation and improving patient outcomes. moving forward, she is likely to continue making strides in the development of advanced drug delivery technologies, with the potential to influence future research in oncology, nanotechnology, and biopharmaceuticals. her expertise in enhancing drug solubility and efficacy positions her as a key player in the future of pharmaceutical biotechnology.
Notable PublicationsÂ
- Title: Enhancing the Antischistosomal Activity of Carvacryl Acetate Using Nanoemulsion
Authors: De Souza, R.L., Mengarda, A.C., Roquini, D.B., Moraes, J.D., Oliveira, E.E.
Journal: Nanomedicine, 2023, 18(4), pp. 331–342
- Title: Nanotechnology as a Tool to Improve the Biological Activity of Carvacrol: A Review
Authors: Souza, R.L.D., Dantas, A.G.B., Melo, C.D.O., FelĂcio, I.M., Oliveira, E.E.
Journal: Journal of Drug Delivery Science and Technology, 2022, 76, 103834
- Title: Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis
Authors: Xavier, E.S., de Souza, R.L., Rodrigues, V.C., Oliveira, E.E., de Moraes, J.
Journal: Frontiers in Pharmacology, 2022, 13, 917363
- Title: The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases
Authors: Da Silva, P.R., Do EspĂrito Santo, R.F., Melo, C.O., de Moura, R.O., Dos Santos, V.L.
Journal: Pharmaceutics, 2022, 14(1), 188
- Title: Xylan Microparticles for Controlled Release of Mesalamine: Production and Physicochemical Characterization
Authors: Urtiga, S.C.D.C., Alves, V.M.O., Melo, C.D.O., Oliveira, E.E., Egito, E.S.T.D.
Journal: Carbohydrate Polymers, 2020, 250, 116929